Literature DB >> 10704957

Do self-reports of perceptual anomalies reflect gating deficits in schizophrenia patients?

G A Light1, D L Braff.   

Abstract

Jin and colleagues presented an innovative study examining P50 suppression and patients' self-reported perceptual anomalies as two related operational measures of sensory gating deficits in schizophrenia patients. They found that those schizophrenia patients who endorsed experiences of sensory inundation had normal levels of P50 suppression, whereas patients who tended to endorse fewer complaints of perceptual anomalies had P50 suppression deficits. Jin et al's finding challenges the common belief that P50 suppression deficits are associated with cognitive and sensory anomalies reflecting poor gating in schizophrenia patients. This article comments on how the dissociation between phenomenological experiences of gating disturbances and P50 suppression might be explained by the limits of self-report in schizophrenia patients who have deficient insight and self-awareness. We hypothesize that the self-reported inability to screen out irrelevant stimuli reflects a voluntary, controlled process that is different from the involuntary, automatic process measured by P50 suppression.

Entities:  

Mesh:

Year:  2000        PMID: 10704957     DOI: 10.1016/s0006-3223(99)00280-2

Source DB:  PubMed          Journal:  Biol Psychiatry        ISSN: 0006-3223            Impact factor:   13.382


  10 in total

1.  Phenomenological dimensions of sensory gating.

Authors:  William P Hetrick; Molly A Erickson; David A Smith
Journal:  Schizophr Bull       Date:  2010-06-04       Impact factor: 9.306

Review 2.  Review of clinical correlates of P50 sensory gating abnormalities in patients with schizophrenia.

Authors:  David Potter; Ann Summerfelt; James Gold; Robert W Buchanan
Journal:  Schizophr Bull       Date:  2006-02-09       Impact factor: 9.306

3.  P50 auditory sensory gating in first onset schizophrenics and normal healthy adults.

Authors:  Hongxing Wang; Mingdao Zhang; Xingshi Chen; Feiying Lou; Jianhua Liang; Chong Chen; Tiantao Shi; Qiulin Lu
Journal:  Front Med China       Date:  2007-10

Review 4.  Sensory processing dysfunction in the personal experience and neuronal machinery of schizophrenia.

Authors:  Daniel C Javitt; Robert Freedman
Journal:  Am J Psychiatry       Date:  2014-11-17       Impact factor: 18.112

5.  Effects of acute and chronic clozapine on D-amphetamine-induced disruption of auditory gating in the rat.

Authors:  Brian Joy; Robert P McMahon; Paul D Shepard
Journal:  Psychopharmacology (Berl)       Date:  2004-07       Impact factor: 4.530

6.  Divergence of subjective and performance-based cognitive gains following cognitive training in schizophrenia.

Authors:  Emily B H Treichler; Michael L Thomas; Andrew W Bismark; William C Hochberger; Melissa Tarasenko; John Nungaray; Lauren Cardoso; Yash B Joshi; Wen Zhang; Joyce Sprock; Neal Swerdlow; Amy N Cohen; Gregory A Light
Journal:  Schizophr Res       Date:  2019-01-16       Impact factor: 4.939

Review 7.  The use of neurophysiological endophenotypes to understand the genetic basis of schizophrenia.

Authors:  David L Braff; Gregory A Light
Journal:  Dialogues Clin Neurosci       Date:  2005       Impact factor: 5.986

8.  EEG-Based Brain Functional Connectivity in First-Episode Schizophrenia Patients, Ultra-High-Risk Individuals, and Healthy Controls During P50 Suppression.

Authors:  Qi Chang; Meijun Liu; Qing Tian; Hua Wang; Yu Luo; Jicong Zhang; Chuanyue Wang
Journal:  Front Hum Neurosci       Date:  2019-11-14       Impact factor: 3.169

9.  Modulation of mGlu2 Receptors, but Not PDE10A Inhibition Normalizes Pharmacologically-Induced Deviance in Auditory Evoked Potentials and Oscillations in Conscious Rats.

Authors:  Abdallah Ahnaou; Ria Biermans; Wilhelmus H Drinkenburg
Journal:  PLoS One       Date:  2016-01-25       Impact factor: 3.240

10.  Age Effect on Automatic Inhibitory Function of the Somatosensory and Motor Cortex: An MEG Study.

Authors:  Chia-Hsiung Cheng; Mei-Yin Lin; Shiou-Han Yang
Journal:  Front Aging Neurosci       Date:  2018-03-02       Impact factor: 5.750

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.